Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis

Francesco Bruno1, Fabrizio D'Ascenzo1, Giorgio Marengo1

  • 1Division of Cardiology, Department of Cardiovascular and Thoracic, Città della Salute e della Scienza Hospital and University of Turin, Turin, Italy.

Insights

Fraction Flow Reserve (FFR) guided Coronary Artery Bypass Grafting (CABG) reduces anastomoses and on-pump procedures. This approach does not increase Major Adverse Cardiac Events (MACE) risk but also does not reduce graft occlusion.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology Assessment

Background:

  • The clinical benefits of Fraction Flow Reserve (FFR) guided Coronary Artery Bypass Grafting (CABG) require further establishment.
  • Current evidence comparing FFR-guided versus angiography-guided CABG is limited.

Purpose of the Study:

  • To evaluate the clinical outcomes of FFR-guided CABG compared to traditional angiography-guided CABG.
  • To assess the impact of FFR guidance on Major Adverse Cardiac Events (MACE) and procedural characteristics.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies.
  • Inclusion criteria encompassed studies with multivariable adjustment comparing FFR-guided and angiography-guided CABG.
  • Primary endpoint was MACE; secondary endpoints included mortality, myocardial infarction, total vessel revascularization (TVR), anastomoses, on-pump procedures, and graft occlusion.

Main Results:

  • Four studies (2 RCTs, 2 observational) with 983 patients were analyzed.
  • No significant difference in MACE, all-cause death, myocardial infarction, or TVR between FFR-guided and angiography-guided CABG.
  • FFR-guided CABG was associated with a reduction in on-pump procedures and the number of anastomoses.

Conclusions:

  • FFR-guided CABG effectively reduces procedural complexity (fewer anastomoses, on-pump procedures) without compromising safety regarding MACE.
  • The study did not find evidence of reduced graft occlusion with FFR-guided CABG.
  • Further research may be warranted to fully elucidate long-term clinical benefits.
Abstract

Related Concept Videos